Fundraising Fox
Ascend Advanced Therapies
Munich, DE · Founded 2022 · 97 employees on LinkedIn · 5 known investors
Find your way into Ascend Advanced Therapies
Sign up to see every warm intro you have to Ascend Advanced Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ascend Advanced Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.
Founders & leadership
Board
Investors · 5
How we know: Cathay Health's portfolio page · Not right? Tell us
How we know: DCVC (Data Collective)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$130.6M disclosed across 1 round · 2024
▶$130.6MraisedNov 2024 · 9 investors · OtherRule 506(b)
- Evis HurseverExecutive Officer
- Michael BeechamDirector
- Andrew KozlovDirector
- Balaji MuralidharDirector
- Fred CohenDirector
- Andrew SinclairDirector
- Wesley McConnellExecutive Officer
- Timothy FunnellDirector
- Michael StellaExecutive Officer, Director
- William HawkinsExecutive Officer
- Justin KernDirector
- Offering amount
- $130.6M
- Amount sold
- $130.6M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Ascend Advanced Therapies.
Frequently asked questions
- What does Ascend Advanced Therapies do?
- Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages. It provides expertise and collaboration to support the development and manufacturing of these therapies.
- Who are Ascend Advanced Therapies's investors?
- Ascend Advanced Therapies's investors include Cathay Health, DCVC (Data Collective), Monograph Capital Partners, 4BIO Capital, Digitalis Ventures.
- How much funding has Ascend Advanced Therapies raised?
- Ascend Advanced Therapies has disclosed $130.6M raised across 1 round.
- Where is Ascend Advanced Therapies headquartered?
- Ascend Advanced Therapies is headquartered in Munich, DE.